{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:46:40Z","timestamp":1792460800865,"version":"4.5.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02674","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T04:16:59Z","timestamp":1542687419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria"],"prefix":"10.3389","volume":"9","author":[{"given":"Manish","family":"Sadarangani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/cid\/cit337","article-title":"Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010","volume":"57","author":"Lamagni","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1473-3099(14)70027-1","article-title":"Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study","volume":"14","author":"Martin","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1185\/03007999909113370","article-title":"Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates","volume":"15","author":"Madore","year":"1999","journal-title":"Curr Med Res Opin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/00006454-199912000-00019","article-title":"Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants","volume":"18","author":"Pichichero","year":"1999","journal-title":"Pediatr Infect Dis J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1128\/CVI.00059-06","article-title":"Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?","volume":"13","author":"Tsai","year":"2006","journal-title":"Clin Vaccine Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/eji.1830031003","article-title":"Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3","volume":"3","author":"Coutinho","year":"1973","journal-title":"Eur J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1542\/peds.52.5.637","article-title":"Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b","volume":"52","author":"Smith","year":"1973","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1086\/317667","article-title":"Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy","volume":"183","author":"Maclennan","year":"2001","journal-title":"J Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/INF.0b013e3180cc2c25","article-title":"Reconsideration of the use of meningococcal polysaccharide vaccine","volume":"26","author":"Granoff","year":"2007","journal-title":"Pediatr Infect Dis J."},{"key":"B13","first-page":"285","article-title":"Postsplenectomy sepsis","volume":"1","author":"Singer","year":"1973","journal-title":"Perspect Pediatr Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/bjs.1800780904","article-title":"Postsplenectomy sepsis and its mortality rate: actual versus perceived risks","volume":"78","author":"Holdsworth","year":"1991","journal-title":"Br J Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s002770050550","article-title":"Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: impact of insufficient antibody response to pneumococcal infection","volume":"78","author":"Eber","year":"1999","journal-title":"Ann Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1198-743x.2001.00355.x","article-title":"Prevention and management of infections in patients without a spleen","volume":"7","author":"Davidson","year":"2001","journal-title":"Clin Microbiol Infect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s100240010145","article-title":"Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited","volume":"4","author":"Hansen","year":"2001","journal-title":"Pediatr Dev Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0891-5520(05)70159-8","article-title":"Infectious complications in asplenic hosts","volume":"15","author":"Sumaraju","year":"2001","journal-title":"Infect Dis Clin North Am."},{"key":"B19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/pbc.20477","article-title":"The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto","volume":"46","author":"Price","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.0900688","article-title":"Human neutrophils kill Streptococcus pneumoniae via serine proteases","volume":"183","author":"Standish","year":"2009","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Ped Infect Dis J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O'brien","year":"2003","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/CVI.00039-13","article-title":"Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy","volume":"20","author":"Ekstrom","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1086\/515298","article-title":"Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines","volume":"177","author":"Anttila","year":"1998","journal-title":"J Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1016\/j.vaccine.2011.04.038","article-title":"Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months","volume":"29","author":"Russell","year":"2011","journal-title":"Vaccine"},{"key":"B29","first-page":"127","article-title":"IgG2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin Exp Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(05)81598-7","article-title":"Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction","volume":"116","author":"Shackelford","year":"1990","journal-title":"J Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.166.5.1351","article-title":"Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies","volume":"166","author":"Bruggemann","year":"1987","journal-title":"J Exp Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1084\/jem.168.1.127","article-title":"Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q","volume":"168","author":"Bindon","year":"1988","journal-title":"J Exp Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1203\/00006450-199004000-00008","article-title":"Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b","volume":"27","author":"Amir","year":"1990","journal-title":"Pediatr Res."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.147.4.1338","article-title":"A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding","volume":"147","author":"Warmerdam","year":"1991","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1086\/314603","article-title":"Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera","volume":"179","author":"Rodriguez","year":"1999","journal-title":"J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2005.08.002","article-title":"Fc[gamma]-receptor IIA genotype and invasive pneumococcal infection","volume":"118","author":"Moens","year":"2006","journal-title":"Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/infdis\/170.4.854","article-title":"Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections","volume":"170","author":"Sanders","year":"1994","journal-title":"J Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1046\/j.1440-1711.2003.01158.x","article-title":"FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection","volume":"81","author":"Yuan","year":"2003","journal-title":"Immunol Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1128\/CVI.00037-09","article-title":"The Fc-gamma receptor IIA-R\/R131 genotype is associated with severe sepsis in community-acquired pneumonia","volume":"16","author":"Endeman","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3181\/00379727-172-41543","article-title":"Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19","volume":"172","author":"Chudwin","year":"1983","journal-title":"Proc Soc Exp Biol Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/infdis\/170.3.592","article-title":"Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae","volume":"170","author":"Vitharsson","year":"1994","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1128\/IAI.00291-08","article-title":"Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway","volume":"76","author":"Yuste","year":"2008","journal-title":"Infect Immun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1128\/CVI.00264-07","article-title":"Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in england and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine","volume":"14","author":"Balmer","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1084\/jem.172.5.1377","article-title":"Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences","volume":"172","author":"Feeney","year":"1990","journal-title":"J Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.immuni.2005.04.011","article-title":"B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S","volume":"23","author":"Haas","year":"2005","journal-title":"pneumoniae. Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.md.0000152371.22747.1e","article-title":"Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease","volume":"84","author":"Jonsson","year":"2005","journal-title":"Medicine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"16969","DOI":"10.1073\/pnas.012669199","article-title":"The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice","volume":"99","author":"Brown","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(02)08516-1","article-title":"MBL genotype and risk of invasive pneumococcal disease: a case-control study","volume":"359","author":"Roy","year":"2002","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.57.4.527","article-title":"An analysis of the opsonic and tropic action of normal and immune sera based on experiements with pneumococcus","volume":"57","author":"Ward","year":"1933","journal-title":"J Exp Med."},{"key":"B50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/IAI.18.2.291-297.1977","article-title":"Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVII, XXII and XXV","volume":"18","author":"Giebink","year":"1977","journal-title":"Infect Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.4049\/jimmunol.170.12.6158","article-title":"Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice","volume":"170","author":"Saeland","year":"2003","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-2249.1993.tb03353.x","article-title":"Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults","volume":"91","author":"Lortan","year":"1993","journal-title":"Clin Exp Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1046\/j.1365-2249.1996.57761.x","article-title":"Function of C3 in a humoral response: iC3b\/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells","volume":"104","author":"Thornton","year":"1996","journal-title":"Clin Exp Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1086\/318833","article-title":"Protection against bacteremic pneumococcal infection by antibody to pneumolysin","volume":"183","author":"Musher","year":"2001","journal-title":"J Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1371\/journal.pmed.0020015","article-title":"Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease","volume":"2","author":"Lipsitch","year":"2005","journal-title":"PLos Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus","volume":"129","author":"Goldschneider","year":"1969","journal-title":"II Development of natural immunity. J Exp Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis","volume":"2","author":"Finne","year":"1983","journal-title":"Implications for vaccine development and pathogenesis. Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2013serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"B60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2334-12-35","article-title":"Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? Experience from the Netherlands","volume":"12","author":"Kaaijk","year":"2012","journal-title":"BMC Infect Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1016\/j.vaccine.2009.05.047","article-title":"Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine","volume":"27","author":"Sakou","year":"2009","journal-title":"Vaccine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1128\/CVI.05354-11","article-title":"Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood","volume":"18","author":"Khatami","year":"2011","journal-title":"Clin Vaccine Immunol."},{"key":"B66","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"B67","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/JCM.26.8.1543-1548.1988","article-title":"Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection","volume":"26","author":"Rosenqvist","year":"1988","journal-title":"J Clin Microbiol."},{"key":"B72","first-page":"169","article-title":"Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies","volume":"14","author":"Rosenqvist","year":"1991","journal-title":"NIPH Ann."},{"key":"B73","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/IAI.63.9.3531-3536.1995","article-title":"Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine","volume":"63","author":"Aase","year":"1995","journal-title":"Infect Immun."},{"key":"B74","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun."},{"key":"B75","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","article-title":"Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans","volume":"66","author":"Haneberg","year":"1998","journal-title":"Infect Immun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0264-410X(98)00259-X","article-title":"Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine","volume":"17","author":"Naess","year":"1999","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1128\/IAI.70.2.584-590.2002","article-title":"Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine","volume":"70","author":"Vermont","year":"2002","journal-title":"Infect Immun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","article-title":"Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease","volume":"21","author":"Aase","year":"2003","journal-title":"Vaccine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1016\/j.vaccine.2005.05.005","article-title":"Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines","volume":"23","author":"Toropainen","year":"2005","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/CVI.00039-07","article-title":"Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines","volume":"14","author":"Wedege","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/ng.640","article-title":"Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"Davila","year":"2010","journal-title":"Nat Genet."},{"key":"B82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00005792-198409000-00001","article-title":"Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency","volume":"63","author":"Ross","year":"1984","journal-title":"Medicine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3201\/eid1010.040335","article-title":"Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America","volume":"10","author":"Pollard","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1128\/CVI.00102-07","article-title":"Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England","volume":"14","author":"Trotter","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1128\/CVI.00036-08","article-title":"Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B","volume":"15","author":"Plested","year":"2008","journal-title":"Clin Vaccine Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization\u2013international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0264-410X(01)00371-1","article-title":"Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine","volume":"20","author":"De Kleijn","year":"2001","journal-title":"Vaccine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJM198710083171503","article-title":"Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin","volume":"317","author":"Santosham","year":"1987","journal-title":"N Engl J Med."},{"key":"B90","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1128\/IAI.56.4.984-986.1988","article-title":"Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy","volume":"56","author":"Rubin","year":"1988","journal-title":"Infect Immun"},{"key":"B91","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.4049\/jimmunol.136.11.4232","article-title":"Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae","volume":"136","author":"Weinberg","year":"1986","journal-title":"J Immunol."},{"key":"B92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.42.1.257-263.1983","article-title":"Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia","volume":"42","author":"Shenep","year":"1983","journal-title":"Infect Immun."},{"key":"B93","first-page":"167","volume-title":"Haemophilus influenzaeVaccines. 6th","author":"Chandran","year":"2013"},{"key":"B94","first-page":"857","article-title":"Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory","volume-title":"Pediatrics","author":"Kayhty","year":"1984"},{"key":"B95","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0264-410X(03)00524-3","article-title":"Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine","volume":"22","author":"Makela","year":"2003","journal-title":"Vaccine"},{"key":"B96","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/01.inf.0000160955.26151.71","article-title":"Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine","volume":"24","author":"Claesson","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/cid\/ciu001","article-title":"Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster","volume":"58","author":"Perrett","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis."},{"key":"B99","first-page":"186","volume-title":"Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis.","author":"Lee","year":"2008"},{"key":"B100","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1172\/JCI109741","article-title":"Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens","volume":"65","author":"Anderson","year":"1980","journal-title":"J Clin Invest."},{"key":"B101","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/infdis\/154.6.935","article-title":"Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination","volume":"154","author":"Musher","year":"1986","journal-title":"J Infect Dis."},{"key":"B102","first-page":"4270","article-title":"The changing epidemiology of invasive Haemophilus influenzae disease: Emergence and global presence of serotype a strains that may require a new vaccine for control","volume-title":"Vaccine","author":"Tsang","year":"2017"},{"key":"B103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3201\/eid2102.140722","article-title":"Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada","volume":"21","author":"Nix","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14745\/ccdr.v43i05a02","article-title":"Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop","volume":"43","author":"Cox","year":"2017","journal-title":"Can Commun Dis Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1016\/j.vaccine.2017.09.055","article-title":"Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: a solution for an unmet public health need","volume":"35","author":"Cox","year":"2017","journal-title":"Vaccine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/14760584.2014.953939","article-title":"Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants","volume":"14","author":"Dangor","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B108","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis."},{"key":"B111","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1128\/IAI.67.8.4303-4305.1999","article-title":"Measurement of human antibodies to type III group B Streptococcus","volume":"67","author":"Kasper","year":"1999","journal-title":"Infect Immun"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1016\/j.vaccine.2012.04.048","article-title":"Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines","volume":"30","author":"Edwards","year":"2012","journal-title":"Vaccine"},{"key":"B113","doi-asserted-by":"publisher","first-page":"568.e13","DOI":"10.1016\/j.cmi.2015.01.030","article-title":"Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women","volume":"21","author":"Kwatra","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1086\/340324","article-title":"Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines","volume":"185","author":"Brigtsen","year":"2002","journal-title":"J Infect Dis"},{"key":"B115","doi-asserted-by":"publisher","first-page":"D52","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants","volume":"31","author":"Madhi","year":"2013","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02674\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T05:14:07Z","timestamp":1694063647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02674\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2018.02674"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02674","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"article-number":"2674"}}